Pdb25 Cost-effectiveness of Insulin Degludec/aspart Versus Biphasic Insulin Aspart in Patients With Type 2 Diabetes in Iran
Year: 2019
Type: conference-abstract
Source: Value in Health
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: bronze
OpenAlex ID: W2995194698
